Peter the Bridge, Saint Petersburg, Russia

News from NEOMED

Pfizer Canada Invests in the NEOMED Institute to Further Support Growth in Quebec’s Life Sciences Sector

June 5th, 2018 |Announcement| No Comments
BOSTON (MA), June 5, 2018 – Pfizer Canada is proud to announce a $1,200,000 contribution to the NEOMED Institute. Pfizer Canada’s support will help NEOMED in its mission to accelerate the transformation of scientific discoveries from Quebec and Canadian universities into innovative therapeutic treatments. Over the next three

Read complete news

GSK and NEOMED call for proposals for innovative early stage human therapeutic projects in Quebec

May 31st, 2018 |Announcement| No Comments
GSK and NEOMED are calling on Quebec-based researchers to submit their innovative projects in early drug discovery for potential funding under the GSK and NEOMED $2 million Discovery Fund. Montreal, QC, Canada May 31st, 2018 – Today, GlaxoSmithKline Inc. (GSK) and the NEOMED Institute (NEOMED) are inviting

Read complete news

The NEOMED Institute Is Attending the 25th BIO International Convention ​in Boston

|Announcement| No Comments
NEOMED’s objectives for BIO: • Identify licensing partners/financial partners for NEOMED’s therapeutic pipeline • Identify new in-licensing opportunities • Showcase NEOMED Innovation Center’s expansion project   Montreal, QC, Canada May 31st, 2018 – The NEOMED Institute an

Read complete news

NEOMED Institute partners with McGill University to identify small molecule inhibitors of a novel oncology target: Cut-Like Homeobox 1 (CUX1)

May 3rd, 2018 |Announcement| No Comments
Montreal, Quebec, Canada May 3rd, 2018 – The NEOMED Institute announced today that it has entered into a development collaboration with McGill University. Dr. Kemal Payza, Senior Project Director at NEOMED Institute will collaborate with Dr. Alain Nepveu, Professor at the Goodman Cancer Research Centre and Departments

Read complete news

© 2018 NEOMED Institute. All Rights Reserved. // Solutions Web Globalia